Gibson Dunn has advised RTW Investments, LP. , Dechert has advised Aquestive Therapeutics, Inc. and Cooley has advised the underwriters. RTW Investments, LP has acquired common...
RTW Investments Leads $85 Million Equity Offering by Aquestive Therapeutics
RTW Investments Acquires Synthetic Royalty Interest in Anaphylm and Participates in Aquestive Therapeutics’ $85 Million Offering
Gibson Dunn has advised RTW Investments, LP. RTW Investments, LP has acquired a synthetic royalty interest in Anaphylm™ (epinephrine) Sublingual Film from Aquestive Therapeutics, Inc. Additionally,...
Concentra Biosciences to Acquire iTeos Therapeutics in Cash and CVR Transaction
Gibson, Dunn & Crutcher LLP has advised Concentra Biosciences, LLC on the transaction, and Ropes & Gray LLP has advised iTeos Therapeutics, Inc. Concentra Biosciences, LLC...
XenoTherapeutics to Acquire ESSA Pharma in All-Cash Agreement Backed by XOMA Royalty
Skadden, Arps, Slate, Meagher & Flom LLP, alongside Blake, Cassels & Graydon LLP, have advised ESSA Pharma Inc. Stikeman Elliott LLP and Gibson, Dunn & Crutcher...
Jade Biosciences’ Merger with Aerovate Therapeutics
Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
GlycoMimetics’ Acquisition of Crescent Biopharma
Sidley Austin is advising GlycoMimetics, Inc. on the transaction, and Gibson, Dunn & Crutcher is advising Crescent Biopharma, Inc. GlycoMimetics, Inc. (NASDAQ: GLYC) announced it has...
ARCA Biopharma’s Merger with Oruka Therapeutics
Wilson Sonsini Goodrich & Rosati is advising ARCA biopharma, Inc. on the transaction, while Gibson, Dunn & Crutcher is advising Oruka Therapeutics and Cooley is advising...
XOMA’s Acquisition of Kinnate Biopharma
XOMA was represented by Gibson, Dunn & Crutcher LLP. XOMA Corporation (NASDAQ: XOMA) announced it has entered an agreement to acquire Kinnate Biopharma Inc. (NASDAQ: KNTE) for a...
Magenta Therapeutics’ Merger with Dianthus Therapeutics
Gibson, Dunn & Crutcher LLP acted for Dianthus Therapeutics, Inc. on its merger with Magenta Therapeutics, Inc., assisted by Goodwin Procter. Magenta Therapeutics, Inc. (Nasdaq: MGTA) and Dianthus Therapeutics,...
Mondelez International Holdings Netherlands B.V.’s €300 Million Exchangeable Bonds Offering
Gibson, Dunn & Crutcher and Loyens & Loeff have advised Mondelez International Holdings Netherlands B.V., while White & Case LLP has advised the Sole Global Coordinator...